CGS-authored
Board chairman says ethical issues will be resolved
Robert N. Klein, chairman of California's new stem cell institute, has moved to reassure supporters and critics alike that no research grants will be issued until ethical safeguards are in place.
Klein has set May as the target for when the first money will go out from the California Institute for Regenerative Medicine, the new research facility created with the passage of Proposition 71 in the November election.
That goal has been met with widespread skepticism. Even some prominent backers of the stem cell program have been voicing concerns that trying to meet the target inevitably will lead to shortcuts that could wind up undermining public support for the enterprise.
During his first full-length interview since assuming the chairmanship of the institute's governing board Dec. 17, Klein insisted late Tuesday night that he never intended to set any firm deadline.
He also expressed regret that he might have failed to explain just what he meant by announcing the May target even before the 29-member stem cell board, known as the Independent Citizens...
Robert N. Klein, chairman of California's new stem cell institute, has moved to reassure supporters and critics alike that no research grants will be issued until ethical safeguards are in place.
Klein has set May as the target for when the first money will go out from the California Institute for Regenerative Medicine, the new research facility created with the passage of Proposition 71 in the November election.
That goal has been met with widespread skepticism. Even some prominent backers of the stem cell program have been voicing concerns that trying to meet the target inevitably will lead to shortcuts that could wind up undermining public support for the enterprise.
During his first full-length interview since assuming the chairmanship of the institute's governing board Dec. 17, Klein insisted late Tuesday night that he never intended to set any firm deadline.
He also expressed regret that he might have failed to explain just what he meant by announcing the May target even before the 29-member stem cell board, known as the Independent Citizens...